Here, we expand on this discussion with additional considerations (Figure 2): 1) Splice Variants and Post-Transcriptional Modifications: The expression of Nav1.5 in cancer is mainly neonatal splice variants, which are regulated by alternative splicing and post-transcriptional modifications. This evidence concerns the gene SCN5A and cancer.